即将在2026年神经科学学会年会(Neuroscience 2026)上公布的新研究表明,生物性别、遗传因素和绝经可能显著影响阿尔茨海默病的风险及对治疗的反应 1。研究发现,绝经期间携带特定基因风险的女性脑部记忆回路更为脆弱,且雌雄小鼠在纤维肌痛敏感性、免疫激活及肠道炎症对大脑的影响方面存在显著差异 1。这些发现强调了考虑性别和遗传差异对于开发针对神经系统疾病更个性化精准疗法的重要性 1。
据世界卫生组织数据,全球约有3500万至4000万人患有阿尔茨海默病,而纤维肌痛影响全球人口的2%至4% 1。多伦多大学研究员Mateja Perović的研究显示,携带阿尔茨海默病遗传风险因素的人群对绝经激素疗法(MHT)的反应与无此风险者不同,且效果随激素组合而异 1。德克萨斯大学健康科学中心圣安东尼奥校区的Stephanie M. Perez通过动物实验表明,经历绝经且携带遗传风险的啮齿动物,其负责记忆的脑回路变得特别脆弱 1。
在慢性疼痛及其他机制研究方面,辛辛那提大学的Yasmin Sahlloul在小鼠纤维肌痛模型中发现,雌性比雄性表现出更高的触觉敏感性和更强的免疫系统激活 1。北达科他大学的Nurcan Kilic则揭示,长期肠道炎症以不同的方式影响雄性和雌性小鼠的脑功能及阿尔茨海默病相关变化 1。成瘾与心理健康中心的Liisa Galea指出,关注女性特异性生物学或性别差异有助于为复杂脑疾病开发更精准的靶向治疗 1。
New research scheduled for presentation at the Neuroscience 2026 annual meeting reveals that biological sex, genetic factors, and menopause significantly influence both the risk of developing Alzheimer’s disease and the effectiveness of treatments 1. With an estimated 35 to 40 million people worldwide living with Alzheimer’s disease according to World Health Organization data, these findings highlight a critical gap in current therapeutic approaches by demonstrating how physiological changes during menopause interact with genetic vulnerabilities 1. The study results underscore the necessity of considering gender-specific biology when designing personalized interventions for complex brain diseases 1.
Specific experimental outcomes indicate distinct pathways through which sex and genetics alter disease progression. Research led by Mateja Perović from the University of Toronto showed that individuals carrying genetic risk factors for Alzheimer’s respond differently to menopausal hormone therapy (MHT) compared to those without such risks, with efficacy varying based on the specific hormone combinations used 1. Additionally, Stephanie M. Perez of the University of Texas Health Science Center at San Antonio demonstrated that rodents experiencing menopause while possessing genetic risks exhibit particular vulnerability in brain circuits responsible for memory 1. Parallel investigations into chronic pain conditions like fibromyalgia, which affects 2 to 4 percent of the global population, further illustrate sexual dimorphism in neurological responses; Yasmin Sahlloul at the University of Cincinnati found female mice exhibited higher tactile sensitivity and stronger immune activation than males in fibromyalgia models 1. Meanwhile, Nurcan Kilic from the University of North Dakota revealed that long-term intestinal inflammation impacts brain function and Alzheimer’s-related changes differently depending on whether the subject is male or female 1. Liisa Galea from the Centre for Addiction and Mental Health emphasized that acknowledging these gender differences is essential for developing more precise, targeted therapies for neurological disorders 1.
评论
还没有评论,欢迎留下第一条。